Abstract
Summary
Intravenous administration of Pitressin causes a significant increase in plasma 17-hydroxycorticosteroid concentration in human subjects.
Get full access to this article
View all access options for this article.
Select search scope: search across all journals or within the current journal
Intravenous administration of Pitressin causes a significant increase in plasma 17-hydroxycorticosteroid concentration in human subjects.
View all access options for this article.